Detecting Reasons for Nonadherence to Medication in Adults with Epilepsy: A Review of Self-Report Measures and Key Predictors
Open Access
- 25 July 2022
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (15) , 4308
Abstract
This review presents individual reasons for self-reported nonadherence in people with epilepsy (PWE). A literature search was performed on the PubMed/Medline and Scopus databases for studies published up to March 2022. Thirty-six studies were included using the following inclusion criteria: original studies on adults with epilepsy, use of subjective self-report adherence measurement methods, and publication in English. Data were extracted using a standardized data extraction table, including the year of publication, authors, cohort size, study design, adherence measurement method, and self-reported reasons for nonadherence. Self-reported reasons for nonadherence were grouped following the WHO model with the five dimensions of nonadherence. In addition, study characteristics and sociodemographic information are reported. Of the 36 included studies, 81% were observational. The average nonadherence rate was nearly 50%. Across all studies, patient-associated, therapy-associated, and circumstance-related factors were the most frequently reported dimensions of nonadherence. These factors include forgetfulness, presence of side-effects, and history of seizures. Regarding healthcare system factors, financial problems were the most reported reason for nonadherence. Stigmatization and quality of life were the most frequently cited factors influencing nonadherence in the disease- and circumstance-related dimensions. The results suggest that interventions for improving adherence should incorporate all dimensions of nonadherence.Keywords
Funding Information
- Bundesministerium für Forschung, Technologie und Raumfahrt (01GY1804)
This publication has 69 references indexed in Scilit:
- Risk factors associated with the epilepsy treatment gap in Kilifi, Kenya: a cross-sectional studyThe Lancet Neurology, 2012
- Suitability of measures of self-reported medication adherence for routine clinical use: A systematic reviewBMC Medical Research Methodology, 2011
- Adherence to antiepileptic drugs and beliefs about medication among predominantly ethnic minority patients with epilepsyEpilepsy & Behavior, 2011
- Medication Adherence: WHO Cares?Mayo Clinic Proceedings, 2011
- Challenges of Treatment Adherence in Older Patients with Parkinson’s DiseaseDrugs & Aging, 2009
- Measuring therapy adherence in Parkinson's disease: a comparison of methodsJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Adherence to MedicationNew England Journal of Medicine, 2005
- Incidence of Epilepsy and Unprovoked Seizures in Rochester, Minnesota: 1935–1984Epilepsia, 1993
- Distribution of Seizure Types in an Epileptic PopulationEpilepsia, 1988
- Concurrent and Predictive Validity of a Self-reported Measure of Medication AdherenceMedical Care, 1986